针对慢性心力衰竭患者在家进行心脏康复的数字治疗方法的成本效益分析:模型开发和数据分析
Tianyi Liu1, Yiyang Zhan2, Silei Chen3
1School of Business, Nanjing University, Nanjing, 210093, China.
Cost effectiveness and resource allocation : C/E
|November 6, 2023
概括
在家进行心脏康复的数字治疗 (DTx) 非常具有成本效益. 这种方法为管理慢性心力衰竭患者的医疗保健决策者提供了重要的价值.
科学领域:
- 心脏病学 心脏病学
- 卫生经济学 卫生经济学
- 数字健康数字健康
背景情况:
- 指南建议数字技术用于心脏康复.
- 数字疗法 (DTx) 通过数字监测提供基于证据的疾病管理.
- 慢性心力衰竭管理受益于创新的治疗方法.
研究的目的:
- 分析DTx在慢性心力衰竭患者的家庭心脏康复中的成本效益.
- 从医疗保健决策者的角度评估DTx的经济价值.
- 提供支持在心脏护理中采用和推广DTx的数据.
主要方法:
- 马尔科夫模型模拟了DTx与传统的家庭心脏康复 (CH).
- 模型输入包括来自现实世界的临床指标和成本数据.
- 经质量调整的寿命年 (QALYs) 和ICERs是关键结果指标,并进行了敏感性分析.
主要成果:
- DTx组的QALY比CH组高 (0.817对0.720每人/年).
- 对于DTx,增量成本效益比 (ICER) 为39663.5元人民币/QALY.
- 这一ICER低于中国2022年人均GDP的支付意愿值.
结论:
- 在家进行心脏康复的DTx是一个非常具有成本效益的选择.
- 对于医疗保健决策者来说,DTx在治疗慢性心力衰竭方面具有重要的潜在价值.
- 这项研究支持将DTx整合到心脏康复计划中.
更多相关视频
07:13Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.3K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
相关概念视频
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure Drugs: Inotropic Agents
598
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598
